Raquel Ciuvalschi Maia Selected Research

Raquel Ciuvalschi Maia Research Topics

Disease

16	Neoplasms (Cancer) 09/2022 - 01/2004
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 11/2008
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2021 - 07/2010
4	Leukemia 08/2012 - 06/2008
2	Breast Neoplasms (Breast Cancer) 10/2019 - 10/2016
1	Carcinogenesis 09/2022
1	Lung Neoplasms (Lung Cancer) 09/2022
1	Carcinoma (Carcinomatosis) 01/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2020
1	Disease Progression 01/2020
1	Splenomegaly 12/2015
1	Anemia 12/2015
1	Primary Myelofibrosis (Myelosclerosis) 12/2015
1	Infections 12/2015
1	Myeloid Leukemia (Leukemia, Myelocytic) 11/2014
1	Blast Crisis (Blast Phase) 12/2012
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2012
1	Neoplasm Metastasis (Metastasis) 12/2011
1	Medulloblastoma 12/2011
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2010
1	Lymphoid Leukemia 07/2010
1	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2009
1	Glioma (Gliomas) 11/2008
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2008
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2003

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 04/2021 - 06/2008
9	SurvivinIBA 01/2020 - 11/2008
8	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2013 - 06/2008
5	Imatinib Mesylate (Gleevec)FDA Link 12/2016 - 11/2008
3	Transcription Factors (Transcription Factor)IBA 12/2019 - 11/2014
2	Pharmaceutical PreparationsIBA 04/2021 - 06/2011
2	LQB 118IBA 12/2019 - 11/2014
2	11a-N-tosyl-5-deoxi-pterocarpanIBA 10/2019 - 10/2016
2	ParaffinIBA 04/2018 - 01/2004
2	Annexin A5IBA 12/2012 - 10/2011
2	Vincristine (Oncovin)FDA LinkGeneric 08/2012 - 10/2011
2	multidrug resistance-associated protein 1IBA 05/2011 - 11/2008
2	DNA (Deoxyribonucleic Acid)IBA 10/2009 - 01/2004
1	MST 312IBA 09/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	OsteopontinIBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2019
1	Formaldehyde (Formol)FDA Link 04/2018
1	Antineoplastic Agents (Antineoplastics)IBA 10/2016
1	Janus Kinase 2IBA 12/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2012
1	Biological ProductsIBA 12/2011
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 06/2011
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 05/2011
1	Monoclonal AntibodiesIBA 07/2010
1	AntioxidantsIBA 11/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2008
1	Inhibitor of Apoptosis ProteinsIBA 11/2008
1	Zoledronic Acid (Zometa)FDA Link 06/2008
1	Pamidronate (Aredia)FDA LinkGeneric 06/2008
1	Diphosphonates (Bisphosphonates)IBA 06/2008

Therapy/Procedure

2	Therapeutics 09/2022 - 08/2003
1	Radiotherapy 04/2018
1	Splenectomy 12/2015